44
Participants
Start Date
February 9, 2022
Primary Completion Date
September 21, 2024
Study Completion Date
December 21, 2024
Active taVNS
Patients will receive transcutaneous auricular vagal nerve stimulation (taVNS) for 5 consecutive days, at the cymba conchae, bilaterally, during 45 minutes (alternating 30 s on and 30 s off periods). Current intensity: 3 mA or less according to the participant's pain threshold, width: 200-300 μsec.
sham taVNS
Patients will receive transcutaneous auricular vagal nerve stimulation (taVNS) for 5 consecutive days, at the ear lobe, bilaterally, during 45 minutes (alternating 30 s on and 30 s off periods). Current intensity: 3 mA or less according to the participant's pain threshold, width: 200-300 μsec.
Centre Neurologique William Lennox, Ottignies-Louvain-la-Neuve
Centre Hospitalier Universitaire de Liège, Liège
University of Liege
OTHER